Synthesis of a Novel Series of Tricyclic Indan Derivatives as Melatonin Receptor Agonists
Authors:
- 15 August 2002
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (19) , 4222-4239
Abstract
To develop a new therapeutic agent for sleep disorders, we synthesized a novel series of tricyclic indan derivatives and evaluated them for their binding affinity to melatonin receptors. In our previous paper, we proposed a conformation of the methoxy group favorable for the binding of the MT1 receptor. To fix the methoxy group in an active conformation, we decided to synthesize conformationally restricted tricyclic indan analogues with the oxygen atom in the 6-position incorporated into a furan, 1,3-dioxane, oxazole, pyran, morpholine, or 1,4-dioxane ring system. Among these compounds, indeno[5,4-b]furan analogues were found to be the most potent and selective MT1 receptor ligands and to have superior metabolic stability. The optimization of substituents led to (S)-(−)-22b, which showed very strong affinity for human MT1 (Ki = 0.014 nM), but no significant affinity for hamster MT3 (Ki = 2600 nM) or other neurotransmitter receptors. The pharmacological effects of (S)-(−)-22b were studied in experimental animals, and it was found that a dose of 0.1 mg/kg, po promoted a sleep in freely moving cats, as demonstrated by a decrease in wakefulness and increases in slow wave sleep and rapid eye movement sleep, which lasted for 6 h after administration. Melatonin (1 mg/kg, po) also had a sleep-promoting effect, though it lasted only 2 h. A new chiral method for the synthesis of (S)-(−)-22b starting from 60, which was prepared from 59 employing asymmetric hydrogenation with the (S)-2,2‘-bis(diphenylphosphino)-1,1‘-binaphthyl−Ru complex, was developed. (S)-(−)-22b (TAK-375) is currently under clinical trial for the treatment of insomnia and circadian rhythm disorders.Keywords
This publication has 43 references indexed in Scilit:
- Chimeric Melatonin mt1 and Melatonin-related ReceptorsJournal of Biological Chemistry, 2000
- Mutagenesis of Human Mel1aMelatonin Receptor Expressed in Yeast Reveals Domains Important for Receptor FunctionBiochemical and Biophysical Research Communications, 1998
- Improvement of sleep quality by controlled-release melatonin in benzodiazepine-treated elderly insomniacsArchives of Gerontology and Geriatrics, 1997
- Synthesis and biological activity of conformationally restricted tricyclic analogs of the hormone melatoninBioorganic & Medicinal Chemistry Letters, 1996
- Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogs of 3,4-(methylenedioxy)amphetamineJournal of Medicinal Chemistry, 1993
- Melatonin and circadian control in mammalsCellular and Molecular Life Sciences, 1989
- HPLC-purified 2-[125I]iodomelatonin labels multiple binding sites in hamster brainBiochemical and Biophysical Research Communications, 1987
- The melatonin message: Duration versus coincidence hypothesesLife Sciences, 1987
- Urinary melatonin rhythms during sleep deprivation in depressed patients and normalsLife Sciences, 1977
- The Utility of Phosphonate Carbanions in Olefin SynthesisJournal of the American Chemical Society, 1961